H-Index & Metrics Best Publications
Javier Martinez-Picado

Javier Martinez-Picado

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 57 Citations 16,780 193 World Ranking 1941 National Ranking 18

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Immune system

His scientific interests lie mostly in Immunology, Viral load, Virology, Virus and Viral replication. His study of Immune system is a part of Immunology. His biological study spans a wide range of topics, including Genome-wide association study, Human leukocyte antigen, Allele and Cellular immunity.

Javier Martinez-Picado has included themes like Protease inhibitor, T cell, Mutant, Epitope and CTL* in his Virology study. His Virus study combines topics from a wide range of disciplines, such as Mutation, Cytotoxic T cell, Nelfinavir and Ritonavir. His work carried out in the field of Viral replication brings together such families of science as Antiretroviral treatment, Antiretroviral therapy, Viremia, Dendritic cell and Pharmacotherapy.

His most cited work include:

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (1068 citations)
  • HIV evolution: CTL escape mutation and reversion after transmission. (788 citations)
  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Virology, Immunology, Viral load, Virus and Immune system. Javier Martinez-Picado studies Virology, focusing on Viral replication in particular. His Immunology research focuses on subjects like Transplantation, which are linked to Stem cell.

His Viral load research is multidisciplinary, relying on both Regimen, Internal medicine, Human leukocyte antigen and Antiretroviral therapy. Javier Martinez-Picado studies Lentivirus which is a part of Virus. Javier Martinez-Picado interconnects Cytotoxic T cell, Receptor, Viral pathogenesis and Vaccination in the investigation of issues within Immune system.

He most often published in these fields:

  • Virology (69.25%)
  • Immunology (67.24%)
  • Viral load (36.21%)

What were the highlights of his more recent work (between 2018-2021)?

  • Immunology (67.24%)
  • Immune system (29.60%)
  • Virology (69.25%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Immunology, Immune system, Virology, SIGLEC and Oncology. His biological study spans a wide range of topics, including Stem cell and Transplantation. His research in Immune system intersects with topics in Cytotoxic T cell and Viral replication.

As part of one scientific family, Javier Martinez-Picado deals mainly with the area of Virology, narrowing it down to issues related to the Gene, and often Human leukocyte antigen. His SIGLEC research focuses on Interferon and how it connects with Microbiology, Transcriptome and Pathogenesis. Specifically, his work in Virus is concerned with the study of Viral load.

Between 2018 and 2021, his most popular works were:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
  • HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation (207 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Immune system

Javier Martinez-Picado focuses on Immunology, Antibody, SIGLEC, Viral load and Immune system. His biological study focuses on Viral replication. His Antibody study combines topics in areas such as Virus, Virology, CD11c and Transplantation.

Javier Martinez-Picado has included themes like Cytoplasm, Monoclonal antibody and In vivo in his Virology study. The study incorporates disciplines such as Viral suppression, Antiretroviral treatment and MEDLINE in addition to Viral load. His Immune system research focuses on Vaccination and how it relates to Immunogenicity and T cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Science (2007)

1307 Citations

HIV evolution: CTL escape mutation and reversion after transmission.

A J Leslie;K J Pfafferott;P Chetty;R Draenert.
Nature Medicine (2004)

961 Citations

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve.
Nature Medicine (2010)

598 Citations

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis.
Science (2020)

548 Citations

Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1

Javier Martinez-Picado;Julia G. Prado;Elizabeth E. Fry;Katja Pfafferott.
Journal of Virology (2006)

522 Citations

Towards an HIV cure: a global scientific strategy

Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane.
Nature Reviews Immunology (2012)

512 Citations

Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

Javier Martinez-Picado;Anu V. Savara;Lorraine Sutton;Richard T. D’Aquila.
Journal of Virology (1999)

479 Citations

Common genetic variation and the control of HIV-1 in humans.

Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo.
PLOS Genetics (2009)

410 Citations

Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.

Rika Draenert;Sylvie Le Gall;Katja J. Pfafferott;Alasdair J. Leslie.
Journal of Experimental Medicine (2004)

364 Citations

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado.
The Lancet (2013)

322 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Javier Martinez-Picado

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 305

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 171

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 135

Zabrina L. Brumme

Zabrina L. Brumme

Simon Fraser University

Publications: 124

Mary Carrington

Mary Carrington

Ragon Institute of MGH, MIT and Harvard

Publications: 115

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 108

Jacques Fellay

Jacques Fellay

École Polytechnique Fédérale de Lausanne

Publications: 103

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 95

Thumbi Ndung'u

Thumbi Ndung'u

University of KwaZulu-Natal

Publications: 82

Jonathan M. Carlson

Jonathan M. Carlson

Microsoft (United States)

Publications: 77

Mark A. Brockman

Mark A. Brockman

Simon Fraser University

Publications: 74

Marcus Altfeld

Marcus Altfeld

Heinrich-Pette-Institute

Publications: 72

James I. Mullins

James I. Mullins

University of Washington

Publications: 68

Todd M. Allen

Todd M. Allen

Ragon Institute of MGH, MIT and Harvard

Publications: 67

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 66

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 63

Something went wrong. Please try again later.